Dermata Therapeutics, Inc. — SCHEDULE 13D/A Filings
7 SCHEDULE 13D/A filings on record
This page lists all SCHEDULE 13D/A filings submitted to the SEC by Dermata Therapeutics, Inc. (DRMAW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Dermata Therapeutics, Inc. has filed 7 SCHEDULE 13D/A documents with the SEC since 2021. To view all SEC filings by Dermata Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
4
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS EX
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D/A | — | 0001493152-26-007792 | Feb 23, 2026 | — |
| SCHEDULE 13D/A | — | 0001493152-26-004801 | Feb 2, 2026 | — |
| SCHEDULE 13D/A | — | 0001493152-26-000967 | Jan 8, 2026 | — |
| SCHEDULE 13D/A | — | 0001641172-25-003085 | Apr 7, 2025 | — |
| SCHEDULE 13D/A | — | 0001641172-25-002621 | Apr 3, 2025 | — |
| SCHEDULE 13D/A | — | 0001493152-25-006502 | Feb 13, 2025 | — |
| SCHEDULE 13D/A | — | 0001493152-25-003484 | Jan 23, 2025 | — |